Accretion Nutraveda IPOon 27 Jan

Accretion Nutraveda IPO (SME)

Accretion Nutraveda IPO is a book building SME issue of Rs. 24.77 crore, comprising a fresh issue of 0.19 crore equity shares aggregating to Rs. 24.77 crore and an offer for sale of 0.00 crore equity shares aggregating to Rs. 0.00 crore. The IPO opens for subscription on Tuesday, January 27, 2026 and closes on Friday, January 30, 2026. The allotment is expected to be finalised on Monday, February 2, 2026, and the shares are proposed to be listed on the BSE SME platform with a tentative listing date of Wednesday, February 4, 2026.

The IPO is offered in a price band of Rs. 122 to Rs. 129 per share with a lot size of 1,000 shares. At the upper price band, the minimum investment for retail investors works out to Rs. 2,58,000 for 2 lots (2,000 shares), while HNI investors are required to apply for a minimum of 3 lots (3,000 shares), amounting to Rs. 3,87,000. Sobhagya Capital Options Pvt. Ltd. is the Book Running Lead Manager to the issue, Kfin Technologies Ltd. is the Registrar, and — is the Market Maker for the IPO.

🕗 Last Update: 20 January 2026, 6.00 AM

👉 GMP | Reviews | Subscription | Allotment

👉 Chanakya Grey Market Intelligence – 8 PM Edition | News Crux | 

👉 Power Calls | Breakout Stocks | Coffee Can Portfolio |

IPO Snapshot

Particulars Details
IPO Type Book Building SME IPO
Issue Size Rs. 24.77 Cr
Fresh Issue 19,20,000 shares (Ex Market Maker) (agg. up to Rs. 24.77 Cr)
Offer for Sale
Face Value Rs. 10 per share
Price Band Rs. 122 to Rs. 129
Lot Size 1,000 shares
Listing Platform BSE SME
Market Cap (Pre-IPO) Rs. 93.40 Cr
Total Issue Size 19,20,000 shares (agg. up to Rs. 24.77 Cr)
Market Maker Reservation 96,000 shares (agg. up to Rs. 1.00 Cr)

IPO Timetable (Tentative)

Event Date
IPO Opens Tue, Jan 27, 2026
IPO Closes Fri, Jan 30, 2026
Allotment Mon, Feb 2, 2026
Refunds Tue, Feb 3, 2026
Credit of Shares Tue, Feb 3, 2026
Listing Wed, Feb 4, 2026

IPO Reservation Structure

Investor Category Shares Offered % of Issue
Market Maker 96,000
QIB 9,08,000
NII (HNI) 2,76,000 14.37%
Retail (RII) 6,40,000 33.33%
Total 19,20,000 100.00%

IPO Lot Size & Investment Amount

Category Lots Shares Amount (Rs.)
Retail (Min & Max) 2 2,000 2,58,000
S-HNI (Min) 3 3,000 3,87,000
S-HNI (Max) 7 7,000 9,03,000
B-HNI (Min) 8 8,000 10,32,000

Issue Management

Role Name
Registrar Kfin Technologies Ltd.
Market Maker
Accretion Nutraveda Ltd. Address 27 Xcelon Industrial Park-1, Vasna-Chacharwadi, TaSanand, Ahmedabad, Gujarat, 382213
Phone / Email +91 9904366177 | compliance@accretionnutraveda.com
Lead Manager Sobhagya Capital Options Pvt. Ltd.

About the business

Accretion Nutraveda Limited was incorporated in 2021 and is engaged in the manufacturing of Ayurvedic and nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations such as balms, creams, and gels.

The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets including Sri Lanka, Singapore, and the USA. Its product approach combines classical Ayurvedic principles with modern nutraceutical science across areas such as liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.

Business verticals

Vertical Revenue Contribution
Domestic Sales & Merchant Exports (Loan License Basis) 96.62%
Direct Exports 3.38%

The company has a manufacturing facility in Gujarat spanning about 10,763 sq. ft., equipped with modern infrastructure including air handling units, separate processing areas, and quality control systems. The facility is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified, and holds an FSSAI license.

Competitive Strengths

Key Strength Commentary
Experienced promoters and management team Execution-led promoters with operational focus
Diverse product portfolio Multiple dosage forms across Ayurveda and nutraceutical categories
Commitment to quality standards Multiple certifications supporting compliance-driven manufacturing
Relationships with clients and suppliers CDMO model supported by repeat business potential
Established business process and management framework System-driven operations with scope to scale

Company Financials (Restated – Rs. Cr.)

Period Ended 31 Mar 2025 31 Mar 2024 31 Mar 2023
Total Assets 10.86 4.64 4.06
Total Income 16.06 5.20 3.07
EBITDA 3.65 1.21 0.59
PAT 2.61 0.82 0.28
Net Worth 5.35 1.08 0.26
Reserves & Surplus 4.86 0.72 -0.10
Total Borrowings 3.86 2.17 1.97

Key Performance Indicators (KPI)

KPI Mar 31, 2025
ROE 81.22%
ROCE 36.98%
Debt / Equity 0.72
RoNW 48.85%
PAT Margin 16.33%
EBITDA Margin 22.79%
Price to Book Value 8.76

Valuation Snapshot

Particulars Pre-IPO Post-IPO
EPS (Rs.) 4.91 3.61
P/E (x) 26.27 35.75
Promoter Holding 100% 73.48%

Objects of the Issue

No. Object Amount (Rs. Cr.)
1 Purchase of machineries for automation in existing manufacturing unit 4.22
2 Purchase of machineries for new manufacturing setup 8.03
3 Funding working capital requirements of the company 5.50
4 General corporate purpose Balance

Promoters

The promoters of the company are Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod, and Mr. Vivek Ashok Kumar Patel.

IPO Registrar

Kfin Technologies Ltd.

Contact Details
Phone 04067162222, 04079611000
Email apl.ipo@kfintech.com
Website Visit Website

IPO Lead Manager(s)

Sobhagya Capital Options Pvt. Ltd.

Contact Details

Particulars Details
Accretion Nutraveda Ltd. Address 27 Xcelon Industrial Park-1, Vasna-Chacharwadi, TaSanand, Ahmedabad, Gujarat, 382213
Phone +91 9904366177
Email compliance@accretionnutraveda.com
 
 

Quicklinks


Disclaimer

This coverage is for informational and educational purposes. Chanakya Ni Pothi does not deal in Grey Market Premiums or recommend investments based on GMP data. Please consult your SEBI-registered investment advisor.